Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

New England Journal of Medicine · 2005 · 5.1K citations · Full text

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

David M. Nathan · Diabetes Care · 2013 · 1.8K citations · Full text

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen et al. · Diabetes Obesity and Metabolism · 2009 · 303 citations · Full text

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

Sally Thrower, Louisa K. James, Wayne Hall et al. · Clinical & Experimental Immunology · 2008 · 148 citations · Full text

Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes

Kristina I. Rother, Lisa M. Spain, Robert Wesley et al. · Diabetes Care · 2009 · 131 citations · Full text